Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 10, 2009

Proteins that Control Proliferation and Mobilization of Blood Stem Cells Discovered

  • Membrane-anchored plasminogen activator, urokinase receptor (MuPAR) and plasmin play key roles in regulating hematopoietic stem/progenitor cells (HSPCs) maintenance, homing, engraftment, and mobilization in the bone marrow, according to scientists at Katholieke Universiteit Leuven.

    Using wild-type and genetically manipulated mice, they found that MuPAR is present on a subset of HSPCs and helps maintain this cell population in bone marrow. When MuPAR was deleted or inhibited, HSPC proliferation was increased and the ability of these cells to home and adhere to the bone marrow microenvironment was inhibited.

    Additionally, MuPAR was inactivated by plasmin via proteolytic cleavage. This inactivation triggered HSPC mobilization.

    Loss of the gene encoding MuPAR also impaired the ability of the HSPCs to repopulate the bone marrow in recipient mice.

    The Journal of Clinical Investigation ran the article in its March 9 online early edition.

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »